Monica Chivulescu

Monica Chivulescu

Auto-generated profile, based on publicly available information

Monica Chivulescu

ProCardio Center for Innovation, Department of Cardiology Oslo University Hospital, Rikshospitalet Oslo Norway

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2021 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
ACAlex Hørby Christensen
Alex Hørby Christensen
PPPyotr G Platonov
Pyotr G Platonov
HJHenrik Kjærulf Jensen
Henrik Kjærulf Jensen
MCMonica Chivulescu
Monica Chivulescu
ASAnneli Svensson
Anneli Svensson
HBHenning Bundgaard
Henning Bundgaard
Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is predominantly caused by desmosomal genetic variants, and clinical hallmarks include arrhythmias and systolic dysfunction. We aimed at studying the impact of the implicated gene(s) on the disease course. Methods: The Nordic ARVC Registry holds data on a multinational cohort of ARVC families. The effects of genotype on electrocardiographic features, imaging findings and clinical events were analysed. Results: We evaluated 419 patients (55% men), with a mean follow-up of 11.2±7.4 years. A pathogenic desmosomal variant was identified in 62% of the 230 families: PKP2 in 41%, DSG2 in 13%, DSP in 7% and DSC2 in 3%. Reduced left ventricular ejection fraction (LVEF) ≤45% on cardiac MRI was more frequent among patients with DSC2/DSG2/DSP than PKP2 ARVC (27% vs 4%, p<0.01). In contrast, in Cox regression modelling of patients with definite ARVC, we found a higher risk of arrhythmias among PKP2 than DSC2/DSG2/DSP carriers: HR 0.25 (0.10–0.68, p<0.01) for atrial fibrillation/flutter, HR 0.67 (0.44–1.0, p=0.06) for ventricular arrhythmias and HR 0.63 (0.42–0.95, p<0.05) for any arrhythmia. Gene-negative patients had an intermediate risk (16%) of LVEF ≤45% and a risk of the combined arrhythmic endpoint comparable with DSC2/DSG2/DSP carriers. Male sex was a risk factor for both arrhythmias and reduced LVEF across all genotype groups (p<0.01). Conclusion: In this large cohort of ARVC families with long-term follow-up, we found PKP2 genotype to be more arrhythmic than DSC2/DSG2/DSP or gene-negative carrier status, whereas reduced LVEF was mostly seen among DSC2/DSG2/DSP carriers. Male sex was associated with a more severe phenotype.

20 August 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
CEChristine Bjørkvik Erevik
Christine Bjørkvik Erevik
ØKØyunn Kleiven
Øyunn Kleiven
VFVidar Frøysa
Vidar Frøysa
MBMagnus Bjørkavoll-Bergseth
Magnus Bjørkavoll-Bergseth
MCMonica Chivulescu
Monica Chivulescu
SØStein Ørn
Stein Ørn
Background: The implications of exercise‐induced cardiac troponin elevation in healthy individuals are unclear. This study aimed to determine if individuals with a high exercise‐induced cardiac troponin I (cTnI) response have alterations in myocardial function following high‐intensity endurance exercise compared with normal‐cTnI responders. Methods and Results: Study individuals were recruited from previous participants in a 91‐km mountain bike cycling race (the North Sea Race) and were classified as high‐ (n=34) or normal‐cTnI responders (n=25) based on maximal cTnI values after the recruitment race. The present study exposed all participants to 2 prolonged high‐intensity exercises: a combined lactate threshold and cardiopulmonary exercise test and repeated participation in the North Sea Race. Echocardiography was performed before, immediately after, and 24 hours following exercise. All study individuals (n=59) had normal coronary arteries, and were aged 51±10 years; 46 (74%) were men. There were no differences in baseline characteristics between the high‐ and normal‐cTnI responders. Maximal cTnI levels 3 hours after exercise were significantly higher in the high‐ compared with normal‐cTnI group ( P <0.001–0.027). Following exercise, there were no differences in global ventricular function between the 2 groups. In contrast, high‐cTnI responders had significantly lower regional strain in the anteroseptal segments following exercise, with more profound changes after the race. Conclusions: High‐cTnI responders had lower anteroseptal segmental strain shortly after exercise than normal‐cTnI responders. However, there were no permanent alterations in myocardial strain, indicating no short‐ or long‐term adverse consequences of these exercise‐induced alterations in myocardial function. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02166216.

1 October 2022 in European Heart Journal
Verified
Journal Article
Open access
PDF file
EAE Aabel
E Aabel
MCM Chivulescu
M Chivulescu
ØLØ H Lie
Ø H Lie
CRC Rootwelt-Norberg
C Rootwelt-Norberg
MRM Ribe
M Ribe
Kristina Hermann HaugaaKristina Hermann Haugaa
Kristina Hermann Haugaa
Background: Arrhythmic mitral valve syndrome is linked to life-threatening ventricular arrhythmias, but the incidence and methods for risk stratification of ventricular arrhythmias are not well known. Purpose: In this prospective study, we aimed to describe the incidence of ventricular arrhythmias by use of continuous rhythm monitoring and propose risk stratification in patients with arrhythmic mitral valve syndrome. Methods: We included consecutive patients with arrhythmic mitral valve prolapse, defined as mitral valve prolapse and/or mitral annulus disjunction (MAD) with arrhythmic symptoms or documented complex premature ventricular complexes (PVC). We implanted loop recorders (ILR) in patients with arrhythmic mitral valve syndrome with no previous severe ventricular arrhythmias and all were followed by remote monitoring. We monitored for non-sustained ventricular tachycardias (NSVT) and severe ventricular arrhythmia, defined as aborted cardiac arrest, sustained ventricular tachycardia and NSVT with syncope/presyncope. At baseline, patients underwent echocardiography, 24-hour Holter monitoring, stress ECG and cardiac magnetic resonance imaging. Results: We included 60 patients (73% female, 49 years [interquartile range [IQR] 37–60]). At baseline, median PVC burden was 232 per 24-hours (IQR 33–1329), and 8 (13%) patients had NSVT by Holter monitoring or stress ECG. During 3.0±0.5 years of follow-up, severe ventricular arrhythmia occurred in 7 (12%) patients (1 aborted cardiac arrest, 6 NSVT with syncope/pre-syncope). Annual incidence rate of severe events was 4% per person-year (95% confidence interval [CI] 2–9)). Predictors of severe ventricular arrhythmia were frequent PVCs (6683 PVCs per 24h [IQR 612–10861] vs. 154 PVCs per 24h [IQR 25–562], p=0.01), more NSVTs by ILR (4 NSVTs [IQR 2–7] vs. 0 NSVTs [0–1], p<0.001), greater left ventricular diameter (57±6 mm vs. 51±6 mm, p=0.01) and greater posterolateral MAD distance (9 mm [IQR 8–12] vs. 4 mm [IQR 0–6], p=0.02). Adjustment for age and sex did not change significant risk markers (all p<0.02). During follow-up 102 NSVTs were recorded in 24 (40%) patients. In multivariate Poisson regression adjusting for age, mitral regurgitation grade and bileaflet prolapse, predictors of high NSVT burden were frequent PVCs (incidence rate ratio [IRR] 1.14 [95% CI 1.04–1.27], p=0.01), PVCs from inferior left ventricle (IRR 5.19 [95% CI 2.80–9.63], p<0.001) and late gadolinium enhancement (IRR 3.16 [95% CI 1.68–5.97], p<0.001). Conclusion: Yearly incidence of first severe ventricular arrhythmia was 4% in patients with arrhythmic mitral valve syndrome, emphasizing the high risk of life-threatening events in these patients. Frequent PVCs, NSVTs, greater left ventricular diameter and greater posterolateral MAD distance were predictors of first severe ventricular arrhythmia and should be used in risk stratification. Funding Acknowledgement: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): This study was supported by a public grant from the Norwegian Research Council (#288438 and #309762), Precision Health Center for optimized cardiac care (ProCardio).